The leading bioengineering and nanotechnology research institute in Australia
AIBN exists to solve some of the world’s most serious problems and some of the projects our research teams are working on, hand in glove with industry, include:
- A research hub dedicated to working with big industry players to reprogram cells to get our society to net zero.
- The BASE facility, which is the country’s largest manufacturer of mRNA vaccines and therapies.
- A second-generation COVID-19 vaccine that has progressed to human trials and a vaccine for respiratory syncytial virus that has progressed to clinical trials.
- Nanotechnologies to create new ways of discovering and treating cancer and some of the world’s rarest diseases.
- The creation of new smart materials to repel bacteria.
- World-leading quantum dot technology for solar energy storage, as well as new materials to create more economical and better batteries.
Working within the AIBN’s labs and leading these projects, we have some of the world’s most recognised academic experts, along with nine of the country’s most cutting-edge research infrastructure facilities. All of which position the AIBN perfectly to enable the future.
Keep up to date with our research
Stay on top of our research news and developments, events and opportunities, by joining The Network
Research areas
Research outcomes
-
-
Can starch be a key ingredient for bioplastics?
13 November 2024 -
Tiny particles in our muscles could be key to treating MND
12 November 2024